4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001209191-19-048640
President and CEO sold 8,581 shares at an average $18.05 ($154,894)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Watts Ryan J. President and CEO | 2019-09-03 | Sale | −3,734 | $18.00 | $67,212 | 2,498,904 | I |
| Watts Ryan J. President and CEO | 2019-09-05 | Sale | −4,847 | $18.09 | $87,682 | 2,494,057 | I |
| Open-market sales · 8,581 sh · avg $18.05 · $154,894 | |||||||
Loading xslF345X03/doc4.xml…